1.Advances in posterior scleral reinforcement for pathological myopia
Zhouyi HUANG ; Hongxia LIAO ; Dongcheng LIU ; Qiuying YE ; Jingwen LIU ; Yijie LU ; Tongmiao WANG ; Bo QIN
International Eye Science 2026;26(8):1400-1404
Pathologic myopia(PM)is characterized by progressive axial elongation, posterior staphyloma, and fundus degenerative changes, representing a leading cause of blindness in Asian countries.Posterior scleral reinforcement(PSR)is currently the only surgical intervention to slow axial elongation. Its mechanisms involve mechanical reinforcement, improved blood circulation, and biological stimulation of scleral remodeling. This article reviews recent advances in PSR: surgical techniques have evolved from complex, classic procedures to standardized single-strip methods, incorporating 3D MRI to quantify posterior staphyloma morphology for personalized graft design and facilitating minimally invasive, precision surgery. Among implant materials, biomaterials such as allogeneic dura mater are being continuously optimized, while biomimetic piezoelectric smart materials actively promote scleral collagen synthesis through electrical signals, achieving a paradigm shift from “passive support”to “active reinforcement”. Clinical outcomes indicate advantages in regulating axial length, enhancing visual function and blood circulation, and facilitating early intervention in children. Combined procedures with ICL implantation, cataract surgery or vitrectomy provide comprehensive treatment regimens for individual patients with varied conditions. This article also analyzes long-term issues and core controversies including ectopic posterior staphyloma and reoperation, and prospects future research directions such as artificial intelligence assistance, translation of smart materials and full-cycle prevention and treatment systems, so as to provide references for clinical practice and scientific research.
2.Application and challenges of artificial intelligence in promoting the development of green hospitals
Modern Hospital 2024;24(7):1116-1118
Against the backdrop of global climate change and environmental degradation,green development has become a key issue in the healthcare industry.This paper takes the Workers'Hospital of Liuzhou as a case study to explore the applica-tion and challenges of artificial intelligence(AI)technology in promoting the development of green hospitals.The paper analyzes in detail the application of AI technology in key areas such as intelligent navigation and triage,smart logistics systems,medical imaging expert systems,image cloud films,and electronic health cards.It demonstrates the significant effects of AI technology in improving medical service efficiency,enhancing patient experience,and optimizing the allocation of medical resources.At the same time,the paper also points out the challenges faced by AI technology in the application process in the medical field,inclu-ding issues of data security and privacy protection.Through case analysis,this paper aims to provide reference and inspiration for other medical institutions,as well as to encourage further research and exploration of the problems and challenges faced by AI technology in the healthcare field.
3.Renchangianin E: a new dibenzocyclooctadiene lignan from Kadsura renchangiana.
Shuang LIU ; Youping LUO ; Yijie HU ; Liqing DENG ; Siyu ZHOU ; Zhihua LIAO ; Daofeng CHEN ; Min CHEN
Acta Pharmaceutica Sinica 2014;49(10):1438-41
A new dibenzocyclooctadiene lignan, renchangianin E (1) was isolated from the stems of Kadsura renchangiana. Its structure and stereochemistry were elucidated by spectroscopic methods, including 2D-NMR techniques.
4.Application of cardiopulmonary bypass during extended resection of locally advanced lung cancer.
Xiangli LIAO ; Shizhi FAN ; Zhiping LI ; Jianming CHEN ; Huijun NIU ; Yong HE ; Yijie HU
Chinese Journal of Lung Cancer 2006;9(4):349-351
BACKGROUNDLocally advanced lung cancer includes IIIA and IIIB lung cancer that tumors are localized within the chest and with no clinic and pathologic distal metastasis. In this study the results of extended resection of a portion of heart or great vessels with cardiopulmonary bypass was summarized in the treatment of locally advanced lung cancer.
METHODSLobectomy or pneumonectomy combined with extended partial excision of the heart or great vessels were carried out in 10 patients with locally advanced lung cancer. The operations included aortic resection and reconstruction with left heart bypass in 2 cases, extended resection of left atrium with normal cardiopulmonary bypass in 5 cases, and resection and reconstruction of superior vena cava in 3 cases respectively.
RESULTSThe patients had no operative complication except for one haemothorax, which was controlled by re-exploration. One patient died of brain metastasis 6 months after operation and another one died of multiple metastasis 26 months after operation. The others were alive.
CONCLUSIONSCPB is a safe and effective anesthetic procedure during extended resection of locally advanced lung cancer although it is controversial for aggravating operative trauma, complex technique and higher cost.


Result Analysis
Print
Save
E-mail